Cooperative Agreement UG3HL179767
Award Date 9/5/25
Completion Date 8/31/27
Dollars Obligated $842K
Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Massachusetts, USA
Similar Awards
- This federal Project Grant award of $708,678, provided by the National Heart, Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to conduct a Sequential Multiple Assignment Randomized Trial (SMART) to reduce food insecurity and improve adherence in patients with hypertension. The key products and services to be delivered under this grant include: Determining the most effective initial food insecurity intervention (resource information or community health worker...
- This Cooperative Agreement award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $744,997 to the University of Oregon to implement and evaluate the effectiveness of a multi-sectoral promotores de salud intervention in rural Oregon's summer meal program. The project aims to promote health and quality of life among Latine families by addressing social determinants of health such as food insecurity, ethnic/language discrimination, and...
- The National Heart, Lung, and Blood Institute awarded a $719,140 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to New York University to conduct the "OPT-FRESH: Optimizing Online Purchasing of Fruits, Vegetables, and Legumes for Low-Income Families" project. The project aims to test a multi-component intervention to address barriers to online healthy food selection among low-income families in New York City, with a focus on increasing the purchase of...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $733,785.00 to President and Fellows of Harvard College, Harvard T.H. Chan School of Public Health, to conduct research on identifying and validating biomarkers of plant-rich diets and their associations with cardiovascular disease risk. The key products and services to be delivered under this grant include: 1) Assessing the dose- and time-dependent...
- The National Institutes of Health's National Heart, Lung and Blood Institute awarded $2,350,623 under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Minnesota on May 1, 2021 for a project concluding on April 30, 2022. The project aims to reduce childhood obesity through an individual randomized controlled trial testing combinations of ecological momentary intervention, home visiting, and video feedback delivered to 510 low-income, racially...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $538,998 Project Grant to Texas A&M AgriLife Research under the Cardiovascular Diseases Research federal grant program (CFDA 93.837). The 4-year "Deep in the Heart" project aims to develop and evaluate a community-engaged intervention to prevent obesity and cardiovascular disease risk factors in rural South Texas women. The project will involve formative research, a multilevel intervention including group classes, a...
- This $237,750 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Temple University aims to investigate the impact of an equity-focused implementation strategy on participation and uptake of Universal School Meals (USM) among students at highest risk for food insecurity and obesity. The project seeks to build on the principal investigator's existing K01 award, utilizing a multi-method approach to determine if the equity-focused...
- The National Heart Lung and Blood Institute awarded a $145,419 Project Grant titled "Implementation Determinants and Community-Based Prevention for Cardiometabolic Disease in Mozambique: A Pilot Study" under the Cardiovascular Diseases Research program (CFDA 93.837). This award supports formative research to characterize determinants for effective implementation of integrated care for type 2 diabetes, hypertension, and HIV within ongoing health systems strengthening efforts in public...
- This $285,195 project grant was awarded on August 20, 2025 by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Brigham & Women's Hospital Inc. to support research on improving hypertension management through patient self-titration of antihypertensive medications. The project aims to adapt this intervention to the U.S. primary care context by assessing patient preferences, provider perspectives, and integration with electronic health records and...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $763,858 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Brigham & Women's Hospital Inc. (a subsidiary of Partners Healthcare System Inc.) to assess the impact of improving cardiovascular disease (CVD) care for adults with diagnosed diabetes across diverse global settings. The project, led by Dr. Jennifer Manne-Goehler and an interdisciplinary team, aims to develop the PREDICT-DM global...